With a treatment cost of $300K/patient/year and 75 patients already on the drug, do the math:
This drug has liver TOX that may kill 75 patients faster once they are on the drug for chronicle period (~6-12 months?)
Sentiment: Strong Sell
@ 3,000 patients that is $900M/year.
@ 10,000 patients between the US & EU that is $3B/year (total available market).
$3B is a good place to start.
Only a complete idiot would be short on this stock.
I wonder what Adam's excuse will be as the revenues pour in each quarter. This quarters earnings beat is just the first of many.
4. patient number is fake (1 patient per million, how many people in US to make up the 6000 patients AEGR and System are talking about? you need to invite people form Fiji/Cuba/Mexico/Seria/North Korea)
One patient per one million births
8300 patient worldwide by 2030
U can treat the dogs or horses from the Derby
postsusers disliked this posts2Reply
What an idiot! Please have respect for very sick patients and their physicians